Sunday in the partner networks came in on “don’t wake us, we’ve already pulled everything” mode: zero fresh wins, but the to-go basket got packed nice and briskly.

🧹 SolCPA pulled the browser in one click

QuantumBrowser for iOS in the US got taken off the shelf. Apparently the app didn’t pass the “why do we need one more browser when people are already glued to Chrome?” check. Sunday, after all: even networks do housekeeping instead of magic.

🛒 Admitad trimmed the product shelf without sentiment

Tulen.store on RU+CIS and VkusVill both flew out of the catalog at once. When both the store and the “easier” store vanish from the shelf in one go, that’s not optimization anymore — that’s classic Admitad dieting: cut anything that looks even slightly untidy. Love for product offers didn’t survive the weekend.

🌍 Italki also headed for the exit

Italki for WW, iOS + Android, was pulled in Admitad. Even broad GEO couldn’t save international language learning: looks like on Sunday the networks decided conversational English can wait, and so can the catalog. Less learning, more counting what got removed — that part is easier.

💊 M1 scrubbed nutra down to a shine

Off the shelf went Inspicure for diabetes and ALVARIX for hypertension — both from M1. Nutra, as usual, lives by the rule “it was there yesterday, today it’s already gone”: capsules, promises, and silence in one package. Not a day, but a sanitation raid on the jars.

📉 Cardiden took a hit on a whole target

For Cardiden in hypertension, low price, on az, 1 target dropped off: from −0 to −1. And that’s the whole drama of the day — not payouts, not growth, just one lonely poke in the stats. Looks like Sunday didn’t come to pump the market, just to quietly flick one offer and go back to sleep.

😼 Day’s total, no fanfare

So, for the window: 0 payout moves, 0 new offers, but 6 pulls and 1 target down. The networks seem to have slept so hard even the cat patrol got tired of waiting. Not a day for a pump — a day for wiping dust and illusions off the shelves.